ChatGPT-Assisted Hypertension Knowledge in Nursing Students
Launched by ANKARA UNIVERSITY · Mar 3, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how the use of ChatGPT, an artificial intelligence tool, can help nursing students learn about hypertension, which is high blood pressure. The study aims to understand both the advantages and limitations of using ChatGPT in nursing education, especially regarding its ability to provide accurate information and support for students. While ChatGPT can quickly deliver research and study materials, there are concerns about its reliability and the importance of personalized care that nurses need to provide to patients.
To participate in this study, you need to be a nursing student enrolled at a private university during the 2024-2025 academic year and have completed a course on Internal Medicine Nursing, which includes training on caring for patients with hypertension. If you decide to join, you can expect to learn about how useful ChatGPT can be in your education while also discussing its potential drawbacks. Remember, if at any point you feel like you want to withdraw from the study, you can do so, and that won’t affect your education.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • To be enrolled in the nursing program at a private university, during the 2024-2025 academic year.
- • To have taken the Internal Medicine Nursing course (In this course, students receive 4 hours of theoretical lessons on nursing care for hypertension patients).
- • To be willing to volunteer for participation in the study.
- Exclusion Criteria:
- • Students who wish to withdraw from the research at any stage will not be included in the study.
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nursemin UNAL, Assoc. Prof.
Principal Investigator
Ankara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported